Sign in

Ruby Wang

@rcjwang.bsky.social
31 followers 29 following 13 posts

ChinaHealthPulse.substack.com 🇬🇧🇨🇳 Doctor, health policy & medtech at LINTRIS Health & Royal Society of Medicine. Prev @ British Embassy Beijing, UNRCO China, British Medical Association, Schwarzman Scholars.

PostsRepliesMedia
Ruby Wang @rcjwang.bsky.social · 22/04/2025
Excited to share my latest post: I break down 5 ways #China is reshaping #globalhealth for the #globalsouth, but not as a #USAID replacement - remote-first #innovation, sovereign #data; public/private integration; community care, traditional blending. Link in comments #healthpolicy #development
110
Ruby Wang @rcjwang.bsky.social · 22/04/2025
Thanks so much @robertpostings.bsky.social !
011
Ruby Wang @rcjwang.bsky.social · 11/04/2025
On 9 April, Trump confirmed incoming Pharma tariffs. This shatters a decades long WTO precedent; that medicines are kept out of trade wars. The consequences: innovation slows. supply chains strain, foreign pharma loses & China hardens. My latest post on the #USChina #tariffs:
100
Ruby Wang @rcjwang.bsky.social · 31/03/2025
Pt 2 of my special deep dive on #China’s #TwoSessions is out now—the only health-focused analysis of this key political event, incl “silver economy”#health #biotech #ageing #healthpolicy I also analyse context of Xi’s recent global CEO meeting — 25 % of the room was big Pharma!
100
Reposted by Ruby Wang
Ruby Wang @rcjwang.bsky.social · 26/03/2025
China’s biotech is getting global attention. In my latest post at <China Health Pulse>, I unpack 4 key truths behind the headlines. Link in comments: #biotech #china #healthtech #healthpolicy #innovation
121
Ruby Wang @rcjwang.bsky.social · 27/03/2025
Was interviewed by <Pharmaceutical Technology> on vaccine market access challenges for foreign pharma in China. These include domestic competition, vaccine hesitancy, regulatory hurdles, disease-specific stigma etc. #vaccines #pharma #china #health www.pharmaceutical-technology.com/features/big...
pharmaceutical-technology.com
Big pharma faces headwinds in China as vaccine sales decline - Pharmaceutical Technology
Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.
000
Ruby Wang @rcjwang.bsky.social · 26/03/2025
China’s biotech is getting global attention. In my latest post at <China Health Pulse>, I unpack 4 key truths behind the headlines. Link in comments: #biotech #china #healthtech #healthpolicy #innovation
121
Ruby Wang @rcjwang.bsky.social · 11/03/2025
Most takes on China’s health are wrong. I debunk 5 of the biggest myths - from inequalities to innovation - because bad assumptions lead to real world consequences. Read my newsletter here: #China #health #healthpolicy #globalhealth #innovation #biotech open.substack.com/pub/chinahea...
open.substack.com
Five Biggest Myths I See About China’s Healthcare
Here’s what everyone keeps getting wrong - and why it really matters.
020
Ruby Wang @rcjwang.bsky.social · 04/03/2025
🚨I launched a newsletter! “China Health Pulse” decodes how China is reshaping health policy, tech, life sciences markets and the future of global health. Clear analysis, real insights—no noise. #China #Health #Biotech #HealthPolicy #Substack Subscribe: open.substack.com/pub/chinahea...
130